https://es.marketscreener.com/cotizacion/accion/ARVINAS-INC-46353308/noticia/Novartis-licencia-un-f-rmaco-contra-el-c-ncer-de-Arvinas-por-hasta-1-000-millones-de-d-lares-46413426/?utm_source=telegram&utm_medium=social&utm_campaign=share